Stocks and Investing
Stocks and Investing
Thu, October 3, 2024
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
[ Thu, Oct 03rd 2024
] - WOPRAI
Raghuram Selvaraju Reiterated (SPRO) at Strong Buy and Held Target at $7 on, Oct 3rd, 2024
Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Spero Therapeutics, Inc." (SPRO) at Strong Buy and Held Target at $7 on, Oct 3rd, 2024.
Raghuram has made no other calls on SPRO in the last 4 months.
There are 2 other peers that have a rating on SPRO. Out of the 2 peers that are also analyzing SPRO, 0 agree with Raghuram's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Raghuram
- Louise Chen of "Cantor Fitzgerald" Reiterated at Buy on, Tuesday, August 6th, 2024
- Ritu Baral of "TD Cowen" Upgraded from Hold to Strong Buy on, Tuesday, August 6th, 2024
Contributing Sources